# Teva

bookmark_icon_off

Viatris formed with merger of Upjohn and Mylan

New company will rival Teva in global generics market.

1 Min Article

bookmark_icon_off

NICE approves first anti-CRGP preparation for migraine

Fremanezumab now available on the NHS in England and Wales for up to 10,000 people.

4 Min Article